UCLE · As filed with the SEC

US Nuclear balance sheet, by fiscal year

The statement as US Nuclear presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

Consolidated Balance Sheets · USD

USDFY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
ASSETS
Cash———126,109
Cash——152,840—
Cash—130,840——
Cash134,779———
Accounts receivable, net213,700351,398342,172329,858
Note receivable39,96641,91621,149—
Inventories1,083,0831,536,0141,761,7832,024,664
Prepaid expenses and other current assets———26,370
Prepaid expenses and other current assets5,63010,000——
TOTAL CURRENT ASSETS1,477,1582,070,1682,277,9442,507,001
Property and equipment, net5241,9644,2176,501
Investments4,5394,5394,53910,059
Acquisition deposit———15,000
Goodwill439,662570,176570,176570,176
TOTAL ASSETS1,921,8832,646,8472,856,8763,108,737
LIABILITIES AND SHAREHOLDERS’ DEFICIT
CURRENT LIABILITIES
Accounts payable217,440256,276207,929100,398
Accounts payable - related party———280,000
Related Party——456,000—
Accrued liabilities1,171,3211,025,9541,020,743688,422
Accrued compensation - officers13,00013,000860,000695,000
Customer deposit——6,77188,694
Deferred revenue——51,578—
Customer deposit—423,548——
Customer deposit117,496———
Notes payable181,924169,624104,3089,574
Convertible notes payable, net of debt discount0405,403600,614412,953
Note payable to shareholder———874,679
Shareholder——1,220,279—
Note payable to shareholder90,33092,512——
Line of credit384,630311,273311,273307,321
TOTAL CURRENT LIABILITIES2,176,1412,697,5904,839,4953,457,041
LONG-TERM LIABILITIES
Notes payable184,433805,422——
Convertible notes payable75,000———
TOTAL LONG-TERM LIABILITIES259,433805,422——
TOTAL LIABILITIES2,435,5743,503,0124,839,4953,457,041
SHAREHOLDERS’ DEFICIT:
Preferred stock, Series A, $0.0001 par value, 10,000 shares authorized, 2,656 and -0- shares issued and outstanding266———
Preferred shares to be issued (2,006 shares)—2,006,000——
Common stock, $0.0001 par value; 100,000,000 shares authorized, 62,822,263 and 52,712,778 shares issued and outstanding6,2835,2714,0173,162
Common shares to be issued (572,660 shares)—45,813——
Common shares to be issued150,060—126,00039,000
Additional paid in capital——16,454,048—
Additional paid-in capital20,478,83816,763,076—14,740,401
Accumulated deficit(21,149,138)(19,676,325)(18,566,684)(15,130,867)
TOTAL SHAREHOLDERS’ DEFICIT(513,691)(856,165)(1,982,619)(348,304)
TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT1,921,8832,646,8472,856,8763,108,737

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.